Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Apr 22, 2004
(April 22, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced 30-day safety data from its clinical trial to evaluate the benefits of stenting in conjunction with embolic protection...
-
Apr 20, 2004
(April 20, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for its first quarter ended March 31, 2004, as well as preliminary information related to U.S. sales...
-
Apr 19, 2004
(April 19, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Express® Biliary...
-
Apr 14, 2004
(April 14, 2004) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31, 2004 on Tuesday, April 20, at 9:00...
-
Apr 8, 2004
(April 8, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced the U.S. launch of its Sentinol™ Self-Expanding Nitinol Biliary Stent System (Sentinol), which has been cleared by...
-
Apr 7, 2004
(April 7, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has acquired Precision Vascular Systems, Inc. (Precision Vascular), a privately held company located in West...
-
Apr 5, 2004
(April 5, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced preliminary results related to U.S. sales of its TAXUS™ Express2™ paclitaxel-eluting coronary stent system and...
-
Apr 1, 2004
(April 1, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that the European Patent Office has declared invalid a patent held by Medinol Ltd. This is the patent that Boston...
-
Mar 31, 2004
(March 31, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has concluded enrollment in its TAXUS V de novo lesion clinical trial. The Company has enrolled 1,172...
-
Mar 29, 2004
(March 29, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Contour SE™...
-
Mar 25, 2004
(March 25, 2004) -- Boston Scientific Corporation (NYSE: BSX) and EndoTex Interventional Systems, Inc. announced today the completion of enrollment in a carotid artery stenting clinical trial to...
-
Mar 22, 2004
(March 22, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced preliminary information related to U.S. sales of its TAXUS™ Express2™ paclitaxel-eluting coronary stent system....
-
Mar 10, 2004
(December 2, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is voluntarily recalling all Stainless Steel Greenfield® Vena Cava Filters with 12Fr Femoral Introducer...
-
Mar 4, 2004
(March 4, 2004) - Boston Scientific Corporation (NYSE: BSX) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market its TAXUS™ Express2™...
-
Mar 4, 2004
(March 4, 2004) - Boston Scientific Corporation (NYSE: BSX) today announced that it has completed a land purchase in Kerkrade, the Netherlands. The site will house the Company's new distribution...
-
Feb 26, 2004
(February 26, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 7th Annual Lehman Brothers' 2004 Global Healthcare Conference, which is being held March 3-5 in...
-
Feb 23, 2004
and New York, NY (February 23, 2004) -- Boston Scientific Corporation (NYSE: BSX) today hosted a meeting with analysts and investors in New York and addressed growth prospects for the Company in...
-
Feb 20, 2004
(February 20, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has entered into an agreement with Guidant Corporation to settle all outstanding litigation between the two...
-
Feb 20, 2004
(February 20, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has made an equity investment in -- and secured an exclusive option to purchase -- Cameron Health, Inc., a...
-
Feb 19, 2004
(February 19, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received a license for the sale of its Carotid Wallstent® Monorail® Endoprosthesis in Canada. The...
-
Feb 18, 2004
(February 18, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has made an equity investment in and secured an exclusive option to acquire Endoscopic Technologies Inc....
-
Feb 17, 2004
(February 17, 2004) -- Boston Scientific Corporation (NYSE: BSX) will simultaneously webcast an analyst meeting it is hosting on Monday, February 23. The meeting is scheduled to begin at 8:30 a.m....
-
Feb 17, 2004
and Maple Grove, MN (February 17, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced major plant and employment expansion plans in Minnesota, headquarters of its Cardiovascular...
-
Feb 9, 2004
(February 9, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has completed its purchase of the Addition Hill Corporate Center in Marlborough, Massachusetts. The site...
-
Feb 6, 2004
(February 6, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that an inspection team from the U.S. Food and Drug Administration (FDA) has completed its inspection of the...
-
Feb 4, 2004
(February 4, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced the start of enrollment in the ARRIVE registry program, which plans to enroll 2,000 patients at approximately 50...
-
Jan 30, 2004
(January 30, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that the United States District Court for the District of Delaware has scheduled a trial for June 2005 in the...
-
Jan 29, 2004
(January 29, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has received reimbursement approval from the French government for its TAXUS™ Express2™...
-
Jan 28, 2004
(January 28, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2004 Merrill Lynch Pharmaceutical, Biotechnology and Medical Device Conference, which is being...
-
Jan 22, 2004
(January 22, 2004) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the fourth quarter and the year ended December 31, 2003 on Monday,...
-
Jan 21, 2004
(January 21, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2004 Piper Jaffray Health Care Conference, which is being held January 27-29 in New York City....
-
Jan 16, 2004
(January 16, 2004) -- Boston Scientific Corporation (NYSE: BSX) announced today that it has completed enrollment of a clinical trial to evaluate the benefits of stenting - in conjunction with...
-
Jan 6, 2004
(January 6, 2004) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 22nd Annual JPMorgan Healthcare Conference, which is being held January 12-15 in San Francisco....